CellPoint Diagnostics

HealthcareSeries AMountain View, UScellpointdiagnostics.com

Latest round

Series A

Last raised

Sep 2007

Total raised

$20M

Investors

2

About CellPoint Diagnostics

, is based in Mountain View, US and is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer. Our novel, proprietary technology captures and analyzes circulating tumor cells (CTCs) directly from patient blood.

Who invested in CellPoint Diagnostics

2 investors across 2 rounds

See all investors in CellPoint Diagnostics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 13, 2007

    Amount

    $11M

    Investors

    Locked

  2. Series A

    Sep 12, 2006

    Amount

    $8.5M

    Investors

    Locked

Questions about CellPoint Diagnostics

Who invested in CellPoint Diagnostics?

CellPoint Diagnostics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CellPoint Diagnostics raised?

CellPoint Diagnostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did CellPoint Diagnostics last raise money?

CellPoint Diagnostics's most recent round on record is a Series A, in Sep 2007.

What does CellPoint Diagnostics do?

, is based in Mountain View, US and is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer.

Where is CellPoint Diagnostics headquartered?

CellPoint Diagnostics is headquartered in Mountain View, US.

Which VCs invest in companies like CellPoint Diagnostics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at CellPoint Diagnostics's stage. Their profiles are linked below.

Raising like CellPoint Diagnostics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.